RBM4-S enhances lung cancer cell proliferation by antagonizing RBM4-FL-meditated tumor suppression through eliminating the inhibition effect of RBM4-FL on the SRSF1-mTORC1 signaling pathway. Here, RBM4 is linked to lung carcinoma.